Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q6)Dec 31, 2025 | (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.61%56.63M | -11.09%142.91M | -13.41%54.65M | 97.17%160.73M | -2.07%63.12M | -61.48%81.52M | -60.29%64.45M | -44.34%211.61M | -3.79%162.3M | 25.65%380.15M |
| Operating income | 3.61%56.63M | -11.09%142.91M | -13.41%54.65M | 97.17%160.73M | -2.07%63.12M | -61.48%81.52M | -60.29%64.45M | -44.34%211.61M | -3.79%162.3M | 25.65%380.15M |
| Cost of sales | -2.09%-52.23M | 13.99%-133.14M | 15.91%-51.16M | -103.47%-154.79M | -4.03%-60.84M | 59.77%-76.08M | 60.98%-58.48M | 44.77%-189.11M | -1.67%-149.87M | -23.41%-342.39M |
| Operating expenses | -2.09%-52.23M | 13.99%-133.14M | 15.91%-51.16M | -103.47%-154.79M | -4.03%-60.84M | 59.77%-76.08M | 60.98%-58.48M | 44.77%-189.11M | -1.67%-149.87M | -23.41%-342.39M |
| Gross profit | 25.88%4.4M | 64.48%9.78M | 53.47%3.49M | 9.19%5.94M | -61.86%2.28M | -75.80%5.44M | -51.98%5.97M | -40.42%22.49M | -41.59%12.43M | 50.52%37.76M |
| Administrative expenses | -4.30%-11.99M | 18.90%-21.66M | 12.08%-11.5M | 2.06%-26.71M | -20.78%-13.08M | 5.58%-27.28M | 3.82%-10.83M | -3.50%-28.89M | -0.45%-11.26M | -9.84%-27.91M |
| Revaluation surplus | ---- | 89.29%-3K | ---- | 98.49%-28K | ---- | 44.19%-1.85M | ---- | 46.89%-3.32M | ---- | 43.01%-6.26M |
| -Changes in the fair value of financial assets | ---- | 89.29%-3K | ---- | 98.49%-28K | ---- | 44.19%-1.85M | ---- | 46.89%-3.32M | ---- | 43.01%-6.26M |
| Impairment and provision | 33.05%-4.64M | 69.25%-6.26M | 40.90%-6.92M | 23.92%-20.35M | -339.47%-11.72M | -28.52%-26.75M | --4.89M | 25.75%-20.81M | ---- | 50.32%-28.03M |
| -Impairment of property, machinery and equipment | ---- | ---1.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.10%-10.11M |
| -Other impairment is provision | 33.05%-4.64M | 74.76%-5.14M | 40.90%-6.92M | 23.92%-20.35M | -339.47%-11.72M | -28.52%-26.75M | --4.89M | -16.13%-20.81M | ---- | -122.34%-17.92M |
| Special items of operating profit | -149.52%-52K | 53.37%-450K | 119.92%105K | -326.53%-965K | 69.68%-527K | 124.15%426K | 66.17%-1.74M | -139.52%-1.76M | 26.99%-5.14M | 300.31%4.46M |
| Operating profit | 17.14%-12.28M | 55.84%-18.6M | 35.68%-14.82M | 15.79%-42.11M | -1,251.50%-23.04M | -54.86%-50.01M | 57.01%-1.71M | -61.67%-32.29M | -230.63%-3.97M | 71.46%-19.97M |
| Financing cost | -118.25%-299K | 9.05%-402K | 53.24%-137K | 65.25%-442K | -15.35%-293K | -783.33%-1.27M | -217.50%-254K | -5.11%-144K | 14.89%-80K | ---137K |
| Share of profits of associates | 1,215.00%223K | ---462K | ---20K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 17.50%-12.36M | 54.27%-19.46M | 35.81%-14.98M | 17.02%-42.55M | -1,091.22%-23.34M | -58.09%-51.28M | 51.58%-1.96M | -61.28%-32.44M | -237.53%-4.05M | 71.18%-20.11M |
| Tax | -3.21%1.03M | 190.17%1.36M | 262.17%1.06M | 17.80%-1.51M | 47.93%-653K | 90.53%-1.83M | 47.90%-1.25M | -141.17%-19.34M | 49.34%-2.41M | -99.06%-8.02M |
| After-tax profit from continuing operations | 18.59%-11.33M | 58.91%-18.1M | 41.97%-13.92M | 17.05%-44.06M | -646.62%-23.99M | -2.58%-53.11M | 50.21%-3.21M | -84.06%-51.77M | -256.72%-6.45M | 61.88%-28.13M |
| Earning after tax | 18.59%-11.33M | 58.91%-18.1M | 41.97%-13.92M | 17.05%-44.06M | -646.62%-23.99M | -2.58%-53.11M | 50.21%-3.21M | -84.06%-51.77M | -256.72%-6.45M | 61.88%-28.13M |
| Minority profit | -101.09%-26K | 14.17%3.66M | -34.82%2.39M | -62.37%3.2M | -42.91%3.67M | 209.58%8.51M | -8.94%6.42M | -485.89%-7.77M | 23.77%7.05M | 82.50%2.01M |
| Profit attributable to shareholders | 30.68%-11.31M | 53.95%-21.76M | 41.02%-16.31M | 23.31%-47.26M | -187.08%-27.65M | -40.03%-61.62M | 28.66%-9.63M | -45.99%-44.01M | -79.92%-13.5M | 59.76%-30.14M |
| Basic earnings per share | 46.88%-0.068 | 70.64%-0.155 | 61.33%-0.128 | 39.66%-0.528 | -138.13%-0.331 | -38.23%-0.875 | -1,332.99%-0.139 | -2,817.05%-0.633 | -79.63%-0.0097 | 59.74%-0.0217 |
| Diluted earnings per share | 46.88%-0.068 | 70.64%-0.155 | 61.33%-0.128 | 39.66%-0.528 | -138.13%-0.331 | -38.23%-0.875 | -1,332.99%-0.139 | -2,817.05%-0.633 | -79.63%-0.0097 | 59.74%-0.0217 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.